Raymond J. Furey - 09 Dec 2022 Form 3 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
EVP, GC & Corp Sec
Signature
/s/ Raymond J. Furey
Issuer symbol
RIGL
Transactions as of
09 Dec 2022
Net transactions value
$0
Form type
3
Filing time
16 Dec 2022, 15:32:42 UTC
Next filing
25 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RIGL Employee Stock Option (right to buy) 09 Dec 2022 Common Stock 187,500 $0.8965 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to this option vest on November 21, 2023, and 1/48th of the shares subject to this option vest in substantially equal monthly installments over the thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney